Novartis AGNovartis AGNovartis AG

Novartis AG

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
1.83USD
Revenue estimate
‪12.27 B‬USD
Market capitalization
‪194.13 B‬USD
‪15.85 B‬USD
‪48.50 B‬USD
‪1.75 B‬
Beta (1Y)
0.67

About NOVARTIS N

CEO
Vasant Narasimhan
Headquarters
Basel
Employees (FY)
‪76.06 K‬
Founded
1996
ISIN
CH0012005267
FIGI
BBG000KSD796
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NVSEF is 96.00 USD — it has increased by 0.94% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Novartis AG stocks are traded under the ticker NVSEF.
Novartis AG is going to release the next earnings report on Jul 18, 2024. Keep track of upcoming events with our Earnings Calendar.
NVSEF stock is 1.71% volatile and has beta coefficient of 0.67. Check out the list of the most volatile stocks — is Novartis AG there?
NVSEF earnings for the last quarter are 1.53 USD per share, whereas the estimation was 1.65 USD resulting in a −7.31% surprise. The estimated earnings for the next quarter are 1.68 USD per share. See more details about Novartis AG earnings.
Novartis AG revenue for the last quarter amounts to ‪11.42 B‬ USD despite the estimated figure of ‪11.88 B‬ USD. In the next quarter revenue is expected to reach ‪11.44 B‬ USD.
Yes, you can track Novartis AG financials in yearly and quarterly reports right on TradingView.
NVSEF stock has risen by 2.35% compared to the previous week, the month change is a 0.91% fall, over the last year Novartis AG has showed a 4.00% decrease.
NVSEF net income for the last quarter is ‪2.61 B‬ USD, while the quarter before that showed ‪8.94 B‬ USD of net income which accounts for −70.85% change. Track more Novartis AG financial stats to get the full picture.
Today Novartis AG has the market capitalization of ‪191.39 B‬, it has increased by 2.88% over the last week.
Yes, NVSEF dividends are paid annually. The last dividend per share was 3.76 USD. As of today, Dividend Yield (TTM)% is 3.69%. Tracking Novartis AG dividends might help you take more informed decisions.
Novartis AG dividend yield was 3.89% in 2023, and payout ratio reached 51.36%. The year before the numbers were 3.83% and 105.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, NVSEF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Novartis AG stock right from TradingView charts — choose your broker and connect to your account.
NVSEF reached its all-time high on Jan 23, 2024 with the price of 109.00 USD, and its all-time low was 34.25 USD and was reached on Mar 10, 2009.
See other stocks reaching their highest and lowest prices.
As of Apr 29, 2024, the company has ‪76.06 K‬ employees. See our rating of the largest employees — is Novartis AG on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Novartis AG technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Novartis AG stock shows the buy signal. See more of Novartis AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Novartis AG future price: according to them, NVSEF price has a max estimate of 130.70 USD and a min estimate of 81.24 USD. Read a more detailed Novartis AG forecast: see what analysts think of Novartis AG and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Novartis AG EBITDA is ‪20.79 B‬ USD, and current EBITDA margin is 44.33%. See more stats in Novartis AG financial statements.